- ENTA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $29.4 million.
- ENTA has traded 81,210 shares today.
- ENTA is down 3% today.
- ENTA was up 10.1% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ENTA with the Ticky from Trade-Ideas. See the FREE profile for ENTA NOW at Trade-Ideas More details on ENTA: Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the infectious disease field in the United States. ENTA has a PE ratio of 24.9. Currently there are 3 analysts that rate Enanta Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Enanta Pharmaceuticals has been 312,600 shares per day over the past 30 days. Enanta has a market cap of $834.8 million and is part of the health care sector and drugs industry. Shares are up 70.9% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.